Tedizolid Suppressive Antimicrobial Therapy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 17
- 试验地点
- 1
- 主要终点
- rate of patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy
研究概览
简要总结
the aim of the study is to describe the management and outcome of patients having an osteo-articular infection treated by tedizolid as a suppressive antibiotic therapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients having an osteo-articular infection treated with tedizolid as a suppressive antibiotic therapy
排除标准
- 未提供
结局指标
主要结局
rate of patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy
时间窗: between 2016 and 2021
proportion of patients having tedizolid as a suppressive antibiotic therapy
rate of failure in patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic
时间窗: 2 years
proportion of patients having a failure under tedizolid as a suppressive antibiotic therapy
rate of adverse event in patients having had a BJI/PJI treated with tedizolid as a suppressive
时间窗: through study completion, an average of 1 year
proportion of patients having a adverse event under tedizolid as a suppressive antibiotic therapy
Description of patients having had a BJI/PJI treated with tedizolid as a suppressive
时间窗: 2 years
type of patients: age, CMI, comorbidities...
Description of BJI/PJI treated with tedizolid as a suppressive
时间窗: 2 years
implant or prothese or not, acute/ chronic, bacteriology
次要结局
未报告次要终点